Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Operating Income (2016 - 2026)

Usana Health Sciences has reported Operating Income over the past 17 years, most recently at $13.9 million for Q2 2026.

  • Quarterly Operating Income fell 11.47% to $13.9 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $35.6 million through Apr 2026, down 37.83% year-over-year, with the annual reading at $37.4 million for FY2026, 43.56% down from the prior year.
  • Operating Income was $13.9 million for Q2 2026 at Usana Health Sciences, up from $3.8 million in the prior quarter.
  • Over five years, Operating Income peaked at $46.2 million in Q1 2022 and troughed at $1.2 million in Q3 2025.
  • The 5-year median for Operating Income is $20.2 million (2022), against an average of $20.3 million.
  • Year-over-year, Operating Income increased 7.4% in 2023 and then plummeted 92.15% in 2025.
  • A 5-year view of Operating Income shows it stood at $22.6 million in 2022, then increased by 7.4% to $24.2 million in 2023, then tumbled by 66.1% to $8.2 million in 2024, then crashed by 85.09% to $1.2 million in 2025, then soared by 1033.5% to $13.9 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Operating Income are $13.9 million (Q2 2026), $3.8 million (Q1 2026), and $1.2 million (Q3 2025).